Tag Archives: StemCells Inc

StemCells Inc. acquired by Israeli medical device company

StemCells Inc. has merged with Microbot Medical.  Recently, the company abandoned their spinal cord injury Phase 2 clinical trial called the Pathway Study. See the full article HERE

Posted in Spinal Research, Stem Cell Research | Tagged

Pathway Study accepting potential Spinal Cord Injury volunteers for trial

Researchers are currently evaluating the potential of stem cell transplantation as a treatment for many neurological disorders, including spinal cord injury (SCI). Stem cells are unique from other cells in the body: •Stem cells can self-renew (make copies of themselves) … Continue reading

Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, Spinal Research, Stem Cell Research | Tagged ,

StemCells, Inc. Announces Webcast to Discuss Interim Results From the First Cohort in Its Phase II Study in Cervical SCI

StemCells, Inc. Announces Webcast to Discuss Interim Results From the First Cohort in Its Phase II Study in Cervical Spinal Cord Injury StemCells, Inc. (NASDAQ:STEM), a world leader in the research and development of cell-based therapeutics for the treatment of … Continue reading

Posted in Regenerative Medicine, Spinal Research, Stem Cell Research | Tagged | 2 Comments

StemCells Inc. moves forward with IND from the FDA

StemCells Inc. announced today that the U.S. Food and Drug Administration, or FDA, has authorized the firm’s Investigational New Drug, or IND, application for clinical testing of its proprietary HuCNS-SC(R) human neural stem cells as a treatment for spinal cord … Continue reading

Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, Stem Cell Research | Tagged

StemCells, Inc.’s Spinal Cord Injury Trial Approved by Health Canada

NEWARK, Jun 03, 2013 (GLOBE NEWSWIRE via COMTEX) — StemCells, Inc. today announced that Health Canada has authorized the Company to expand its Phase I/II clinical trial for chronic spinal cord injury into Canada. The Phase I/II trial, currently underway … Continue reading

Posted in Advocacy, Chronic Spinal Cord Injury Research, Regenerative Medicine, Spinal Research, Stem Cell Research | Tagged ,

CNS Panel Discussion, StemCells Inc. and Asterias Biotherapeutics at Alliance for Regenerative Medicine Investor Day

The Alliance for Regenerative Medicine (ARM) is a Washington, DC-based multi-stakeholder advocacy organization that promotes legislative, regulatory and reimbursement initiatives necessary to facilitate access to life-giving advances in regenerative medicine. ARM also works to increase public understanding of the field … Continue reading

Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, Rehabilitation, Spinal Research, Stem Cell Research | Tagged , , , , , , , , , , , , , , , , , , ,

Meet the Scientists 2013 at RIRC

This years Meet the Scientists saw a great turnout of dedicated paralysis cure supporters. This forum was an open question and answer session that allowed the community to ask the researchers directly the burning questions. The exciting presentations wrapped with … Continue reading

Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, Rehabilitation, Spinal Research, Stem Cell Research | Tagged , , , , , , , , , , , , , , , , , , ,

What the Community Wants to Know! Aileen Anderson PhD, Stephen Huhn MD and Dr Thomas Answer Questions about StemCells Inc.

These online video presentations from the W2W 2012 symposium are only made possible through your generous contributions to U2FP. Aileen Anderson PhD,  Stephen Huhn MD, Dr. Jonathan Thomas answer questions about the StemCells Inc. human clinical trial in Zurich.

Posted in Advocacy, Chronic Spinal Cord Injury Research, Regenerative Medicine, Rehabilitation, Spinal Research, Stem Cell Research, Unite 2 Fight Paralysis, Working 2 Walk Science & Advocacy Symposium | Tagged , , , , , , , , , , , , , , , , , , , , ,

CDRF Board votes to assist an Irvine lab presented at Working 2 Walk 2012

On the heels of last weeks announcement by the ISRT in the U.K. to fund two progressive translational chronic SCI research projects seen at Working 2 walk 2012 in California, comes an announcement this week from CDRF. Peter Wilderotter, CEO … Continue reading

Posted in Advocacy, Chronic Spinal Cord Injury Research, Regenerative Medicine, Rehabilitation, Spinal Research, Stem Cell Research, Unite 2 Fight Paralysis, Working 2 Walk Science & Advocacy Symposium | Tagged , , , , , , , ,

Canadian stem cell trials impeded by federal regulations, doctors say

When a Swiss-based researcher announced this month he had achieved some improvement in profoundly paralyzed spinal-cord-injury patients with an injection of stem cells, he generated headlines worldwide. Dr. Armin Curt’s findings were the first evidence from actual humans — though … Continue reading

Posted in Advocacy, Chronic Spinal Cord Injury Research, Regenerative Medicine, Stem Cell Research | Tagged , , , , , , , , , | 2 Comments